Inhalable hybrid nanocarriers for respiratory disorders-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhalable hybrid nanocarriers for respiratory disorders

Published:2020 Issue: Volume: Page:281-302
ISSN:
Container-title:Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems
language:
Short-container-title:

Author:

Maurya Priyanka,Singh Samipta,Saraf Shubhini A.

Publisher

Elsevier

Reference102 articles.

1. Recent advances in controlled pulmonary drug delivery;Liang;Drug Discov Today,2015

2. Pulmonary drug delivery systems for tuberculosis treatment;Pham;Int J Pharm,2015

3. A review on recent technologies for the manufacture of pulmonary drugs;Hadiwinoto;Ther Deliv,2018

4. Development of an inhalable, stimuli-responsive particulate system for delivery to deep lung tissue;Abbas;Colloids Surf B: Biointerfaces,2016

5. Strategies to enhance drug absorption via nasal and pulmonary routes;Ghadiri;Pharmaceutics,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Latest Delivery Advancements of Lipid Nanoparticles for Cancer Treatment;ASSAY and Drug Development Technologies;2024-09-01

2. Liposomes like advanced drug carriers: from fundamentals to pharmaceutical applications;Journal of Microencapsulation;2024-07-11

3. Current advances in the therapeutic potential of nanomedicines for pulmonary disorders;Emergent Materials;2024-04-24

4. Nanoliposome: As a smart nanocarrier in transdermal drug delivery system;Intelligent Pharmacy;2024-04

5. Nano vs Resistant Tuberculosis: Taking the Lung Route;AAPS PharmSciTech;2023-12-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP